Puma Biotechnology, Inc.

Release Summary

Puma Biotechnology announced that four abstracts on its drug candidate PB272 (neratinib) were released by the American Society of Clinical Oncology (ASCO) and will be presented at the annual meeting.

Puma Biotechnology, Inc.